Floatz logo

Immunoglobulin G1 [143-aspartic acid,236-glutamic acid], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal HBM4003 heavy chain V-D-J region) fusion protein with immunoglobulin G1 (human ?1-chain C region), dimer

Solid Tumors

Harbour BioMed (Guangzhou) Co. Ltd.monoclonal_antibodyPhase 1Active
C
37/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
65/ 100

Competitive context

927 Active assets in the Solid Tumors cohort.

Asset / SponsorPhaseRating
PANITUMUMAB
Astellas Pharma Inc
Phase 2BBB
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM
Sanofi
Phase 4BB
Inno-206
The First Affiliated Hospital of Soochow University
Phase 2/3BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
Glycopyrrolate
Medical College of Wisconsin
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1 [143-aspartic acid,236-glutamic acid], anti-(human cytotoxic T-lymphocyte-associated protein 4) (human monoclonal HBM4003 heavy chain V-D-J region) fusion protein with immunoglobulin G1 (human ?1-chain C region), dimer is also rated in:

colorectal cancerDormant
CC
Indicative ·
41 / 100
View asset →
neuroendocrine neoplasmDormant
C
Indicative ·
39 / 100
View asset →
cancerDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →